248 related articles for article (PubMed ID: 25173233)
1. EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition.
Zhang Y; Wang SX; Ma JW; Li HY; Ye JC; Xie SM; Du B; Zhong XY
J Neurooncol; 2015 Jan; 121(1):41-52. PubMed ID: 25173233
[TBL] [Abstract][Full Text] [Related]
2. Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression.
Zhang Y; Wen YL; Ma JW; Ye JC; Wang X; Huang JX; Meng CY; Xu XZ; Wang SX; Zhong XY
Int J Oncol; 2017 Jan; 50(1):101-110. PubMed ID: 27909720
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y
J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
5. Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.
Qiu ZK; Shen D; Chen YS; Yang QY; Guo CC; Feng BH; Chen ZP
Chin J Cancer; 2014 Feb; 33(2):115-22. PubMed ID: 23958055
[TBL] [Abstract][Full Text] [Related]
6. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
7. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
8. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.
Liu N; Hu G; Wang H; Li Z; Guo Z
J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120
[TBL] [Abstract][Full Text] [Related]
9. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.
Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC
Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595
[TBL] [Abstract][Full Text] [Related]
10. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST
J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571
[TBL] [Abstract][Full Text] [Related]
11. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
12. Effect of IFN-beta on human glioma cell lines with temozolomide resistance.
Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E
Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS
Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
15. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
[TBL] [Abstract][Full Text] [Related]
18. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells.
Ma J; Yang YR; Chen W; Chen MH; Wang H; Wang XD; Sun LL; Wang FZ; Wang DC
Oncol Rep; 2016 Aug; 36(2):676-84. PubMed ID: 27278525
[TBL] [Abstract][Full Text] [Related]
20. β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.
Feng HB; Wang J; Jiang HR; Mei X; Zhao YY; Chen FR; Qu Y; Sai K; Guo CC; Yang QY; Zhang ZP; Chen ZP
Stem Cells Transl Med; 2017 Mar; 6(3):830-839. PubMed ID: 28297578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]